Back to Search
Start Over
Mycoplasma genitalium and sexually transmitted infections: evidences and figures in a tertiary hospital.
- Source :
-
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2022 Feb; Vol. 35 (1), pp. 76-79. Date of Electronic Publication: 2021 Dec 17. - Publication Year :
- 2022
-
Abstract
- Objective: Mycoplasma genitalium is an emerging cause of sexually transmitted infections (STIs) and has been implicated in non-gonococcal urethritis in men and cervicitis in woman. The aim of this study is determinate the incidence and pathogenicity of M. genitalium within the diagnosis of STIs detected from clinical samples in a third level hospital.<br />Methods: A total of 8,473 samples from endocervix, urethra, vagina, rectum and others were processed applying Allpex STI Essential Assay. More than 190 records were reviewed to determinate M. genitalium pathogenicity.<br />Results: M. genitalium was detected in a rate 2.8%. Co-infections were detected in 20% of the patients.<br />Conclusions: M. genitalium is considered a STI emerging pathogen thanks to the renewal of multiplex-PCR tests although with a low incidence in our approach. Emerging from our experience and the institutional recommendations both detection of acid nucleic techniques (NAATs) and gonococcal culture might be implemented accurately and coexist to adequate prescriptions.<br /> (©The Author 2021. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).)
Details
- Language :
- English
- ISSN :
- 1988-9518
- Volume :
- 35
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
- Publication Type :
- Academic Journal
- Accession number :
- 34915694
- Full Text :
- https://doi.org/10.37201/req/091.2021